176 related articles for article (PubMed ID: 23640355)
1. First- and second-generation drug-eluting balloons for femoro-popliteal arterial obstructions: update of technique and results.
De Vries JP; Karimi A; Fioole B; Van Leersum M; Werson DA; Van Den Heuvel DA
J Cardiovasc Surg (Torino); 2013 Jun; 54(3):327-32. PubMed ID: 23640355
[TBL] [Abstract][Full Text] [Related]
2. Peripheral drug-eluting technology.
Franzone A; Stabile E; Trimarco B; Esposito G
Cardiol Clin; 2015 Feb; 33(1):151-62. PubMed ID: 25439337
[TBL] [Abstract][Full Text] [Related]
3. The potential role of DES in peripheral in-stent restenosis.
Zeller T; Macharzina R; Tepe G
J Cardiovasc Surg (Torino); 2010 Aug; 51(4):561-5. PubMed ID: 20671640
[TBL] [Abstract][Full Text] [Related]
4. Femoropopliteal in-stent restenosis: review and potential for drug based therapy.
Phillips J; Ansel G
J Cardiovasc Surg (Torino); 2013 Jun; 54(3):333-6. PubMed ID: 23640356
[TBL] [Abstract][Full Text] [Related]
5. Standard balloon angioplasty versus angioplasty with paclitaxel-eluting balloons for femoropopliteal artery stenosis.
Ju MH; Rodríguez HE
J Cardiovasc Surg (Torino); 2012 Aug; 53(4):459-63. PubMed ID: 22854525
[TBL] [Abstract][Full Text] [Related]
6. Drug-coated balloons versus drug-eluting stents in the femoropopliteal artery: comparing apples to oranges?
Ansel GM
J Cardiovasc Surg (Torino); 2019 Aug; 60(4):456-459. PubMed ID: 30994309
[TBL] [Abstract][Full Text] [Related]
7. Drug eluting balloons.
Diehm NA; Hoppe H; Do DD
Tech Vasc Interv Radiol; 2010 Mar; 13(1):59-63. PubMed ID: 20123434
[TBL] [Abstract][Full Text] [Related]
8. Drug-coated balloons to improve femoropopliteal artery patency: Rationale and design of the LEVANT 2 trial.
Jaff MR; Rosenfield K; Scheinert D; Rocha-Singh K; Benenati J; Nehler M; White CJ
Am Heart J; 2015 Apr; 169(4):479-85. PubMed ID: 25819854
[TBL] [Abstract][Full Text] [Related]
9. 12-month primary patency rates of contemporary endovascular device therapy for femoro-popliteal occlusive disease in 6,024 patients: beyond balloon angioplasty.
Marmagkiolis K; Hakeem A; Choksi N; Al-Hawwas M; Edupuganti MM; Leesar MA; Cilingiroglu M
Catheter Cardiovasc Interv; 2014 Oct; 84(4):555-64. PubMed ID: 24740749
[TBL] [Abstract][Full Text] [Related]
10. Does endovascular treatment of infra-inguinal arterial disease with drug-eluting stents offer better results than angioplasty with or without bare metal stents?
Antoniou GA; Georgakarakos EI; Antoniou SA; Georgiadis GS
Interact Cardiovasc Thorac Surg; 2014 Aug; 19(2):282-5. PubMed ID: 24729201
[TBL] [Abstract][Full Text] [Related]
11. One-year outcome of the paclitaxel-eluting Legflow balloon catheter in the treatment of long and complex femoropopliteal lesions.
Bosiers M; Deloose K; Torsello G; Scheinert D; Verbist J; van den Eynde W; Maene L; Beelen R; Keirse K; Hendriks J; Callaert J; Bosiers M; Wauters J
J Cardiovasc Surg (Torino); 2020 Aug; 61(4):471-477. PubMed ID: 32241092
[TBL] [Abstract][Full Text] [Related]
12. Drug-coated balloons vs. drug-eluting stents for treatment of long femoropopliteal lesions.
Zeller T; Rastan A; Macharzina R; Tepe G; Kaspar M; Chavarria J; Beschorner U; Schwarzwälder U; Schwarz T; Noory E
J Endovasc Ther; 2014 Jun; 21(3):359-68. PubMed ID: 24915582
[TBL] [Abstract][Full Text] [Related]
13. [Remote results of angioplasty using drug-coated balloons in lesions of the femoropopliteal segment].
Zatevakhin II; Shipovskiĭ VN; Tursunov SB; Bagdat'ev VE; Dzhurakulov ShR
Angiol Sosud Khir; 2014; 20(4):64-8. PubMed ID: 25490359
[TBL] [Abstract][Full Text] [Related]
14. [Drug-Coated Balloons and Stents for the Treatment of Femoro-Popliteal Lesions].
Ito WD
Dtsch Med Wochenschr; 2017 Aug; 142(15):1093-1096. PubMed ID: 28763816
[No Abstract] [Full Text] [Related]
15. The SELUTION SLR™ drug-eluting balloon system for the treatment of symptomatic femoropopliteal lesions.
Böhme T; Noory E; Beschorner U; Macharzina R; Zeller T
Future Cardiol; 2021 Mar; 17(2):257-267. PubMed ID: 32815739
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous vascular interventions in the superficial femoral artery. A review.
Wiesinger B; Heller S; Schmehl J; Claussen CD; Wiskirchen J; Tepe G
Minerva Cardioangiol; 2006 Feb; 54(1):83-93. PubMed ID: 16467744
[TBL] [Abstract][Full Text] [Related]
17. Advances in below-the-knee drug-eluting balloons.
Ferraresi R; Centola M; Biondi-Zoccai G
J Cardiovasc Surg (Torino); 2012 Apr; 53(2):205-13. PubMed ID: 22456643
[TBL] [Abstract][Full Text] [Related]
18. Drug-eluting stents for treatment of focal infrapopliteal lesions.
Rastan A; Noory E; Zeller T
Vasa; 2012 Mar; 41(2):90-5. PubMed ID: 22403126
[TBL] [Abstract][Full Text] [Related]
19. [Drug-coated balloons in the treatment of peripheral artery disease (PAD). History and current level of evidence].
Herten M; Stahlhoff S; Imm B; Schönefeld E; Schwindt A; Torsello GB
Radiologe; 2016 Mar; 56(3):240-53. PubMed ID: 26885653
[TBL] [Abstract][Full Text] [Related]
20. Are drug-eluting stents the future of SFA treatment?
Bosiers M; Deloose K; Keirse K; Verbist J; Peeters P
J Cardiovasc Surg (Torino); 2010 Feb; 51(1):115-9. PubMed ID: 20081767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
